DISCLAIMER:
Entry of taxonomy/keywords during proffered abstract submission was optional.
Not all abstracts will appear in search results.
Keywords: Radiosensitivity
| PO-GePV-T-213 | Sub-Segmentation of Laryngopharynx Whole-Mean Dose Constraints for Reducing Intra-Organ Dose Variability C Sample1*, H Clark2, (1) British Columbia Cancer Agency, Vancouver, BC, CA, (2) British Columbia Cancer Agency, Surrey, BC, CA |
| PO-GePV-T-331 | Photoelectric Dose-Enhancement Using FDA-Approved Materials W Swanson1*, Y Hao2, W Ngwa3, (1) University of Massachusetts Lowell, Lowell, MA, (2) Washington University School of Medicine, St. Louis, MO, (3) Brigham and Womens Hospital, Boston, MA |
| PO-GePV-T-434 | Investigate Depth-Dependent Dose Enhancement of PSMA-Targeted Gold Nanoparticles Assisted Radiosensitization at Megavoltage Energy D Hara*, J Shi, R Schmidt, W Tao, W Ma, N Dogan, J Ford, A Pollack, University of Miami, Miami, FL, |
| PO-GePV-T-440 | Radiation Cell Survival Fraction After a FLASH Radiation Pulse S Zhou1*, Y Yan1, D Zheng1, S Wang1, S Wisnoskie1, D Umstadter2, (1) University of Nebraska Medical Center, Omaha, NE, (2) University Of Nebraska-Lincoln, Lincoln, NE |
| TH-F-TRACK 4-1 | A Non-Parametric Analysis to Identify High-Risk Vs. Low-Risk Anatomic Regions Associated with Reduced Overall Survival in the RTOG 0617 Clinical Trial Data J Zhu1*, M Thor2*, A Apte2, J Oh2, A Rimner2, J Deasy2, A Tannenbaum1, (1) Stony Brook University, Stony Brook, NY, (2) Memorial Sloan Kettering Cancer Center, New York, NY |
| TU-AB-TRACK 5-0 | Radiation as a Biological Rather Than a Physical Tool to Combat Cancer A McNamara1*, J Eley2*, S Bright3*, W Ngwa4*, (1) Mass General Hospital and Harvard Medical School, Boston, MA, (2) Vanderbilt University School of Medicine, Nashville, TN, (3) UT MD Anderson Cancer Center, Houston, TX, (4) Brigham and Women's Hospital, Boston, MA |
| TU-C-TRACK 6-5 | Nanoparticle-Mediated Assessment of ROS and Radiosensitization of Brain Cancer Cells for Improved Radiotherapy Outcomes C Thiegs*, K Djam, H Kramer, Y Walter, A Hubbard, A Benoit, E Yank, O Salas, M Schwengler, J Lewison, S Mckinley, A Ekpenyong, Creighton University, Omaha, NE |
| TU-D-TRACK 6-1 | ATR Inhibition Suppresses DNA Damage Signaling and Sensitizes Cancer Cells to Photons and Protons D Martinus*, S Bright, D Flint, B Turner, M Manandhar, M Ben Kacem, S Shaitelman, G Sawakuchi, UT MD Anderson Cancer Center, Houston, TX |